2025-09-10 16:58 SJ |
Food: 16g M Assist Feed + 1 whole mouse placed in kennel Meloxicam: 0.20 ml (1.5 mg/ml soln) PO Ketorolac - OU -
|
2025-09-10 09:33 SJ |
Food: 15g M Assisted Feeding Meloxicam: 0.20 ml (1.5 mg/ml soln) PO Ketorolac - OU -
BAR, normal mutes, no pellet, 26g leftovers
|
2025-09-09 16:31 MR |
Food: 15g M (Do NOT Assist Feed) Watch food intake carefully Meloxicam: 0.20 ml (1.5 mg/ml soln) PO Ketorolac - OU -
|
2025-09-09 10:07 RE |
Food: 17g M (Do NOT Assist Feed) Watch food intake carefully Meloxicam: 0.20 ml (1.5 mg/ml soln) PO Ketorolac - OU -
BAR, no pellet, normal mutes, 14g leftovers
|
2025-09-08 16:52 SAK |
Food:15g M Meloxicam: 0.20 ml (1.5 mg/ml soln) PO Ketorolac - OU -
|
2025-09-08 11:10 SAK |
======= TREATMENT PLAN ======= NPO Buprenorphine SR: 0.05 ml (1.8 mg/ml SR) SQ on 2025-09-11, 2025-09-15, 2025-09-18, 2025-09-22 Meloxicam: 0.20 ml (1.5 mg/ml soln) BID PO Ketorolac - OU BID - PT: PROM Left wing - under anesthesia ==============================
|
2025-09-08 11:08 SAK |
======= TREATMENT PLAN ======= NPO Buprenorphine SR: 0.05 ml (1.8 mg/ml SR) SQ on 2025-09-11, 2025-09-15, 2025-09-18, 2025-09-22 Meloxicam: 0.20 ml (1.5 mg/ml soln) BID PO Ketorolac - OU BID - PT: PROM Left wing - under anesthesia ==============================
|
2025-09-08 10:14 SAK |
NPO Buprenorphine SR: 0.05 ml (1.8 mg/ml SR) SQ Meloxicam: 0.20 ml (1.5 mg/ml soln) PO Ketorolac - OU - PT: PROM Left wing - under anesthesia
|
2025-09-08 10:13 SJ |
BAR, normal mutes, one pellet, no regurgitation
|
2025-09-07 17:16 SAK |
======= TREATMENT PLAN ======= Assisted feed: 15g M Cut up BID Buprenorphine SR: 0.05 ml (1.8 mg/ml SR) SID SQ Meloxicam: 0.20 ml (1.5 mg/ml soln) BID PO Ketorolac - OU BID - ==============================
|
2025-09-07 16:51 SAK |
Assisted feed: 15g M Cut up Meloxicam: 0.20 ml (1.5 mg/ml soln) PO Ketorolac - OU -
|
2025-09-07 12:51 SAK |
Assisted feed: 13g M Cut up Buprenorphine SR: 0.05 ml (1.8 mg/ml SR) SQ Meloxicam: 0.20 ml (1.5 mg/ml soln) PO Ketorolac - OU -
|
2025-09-07 09:00 SJ |
BAR, normal mutes, no leftovers, one pellet
|
2025-09-06 17:27 RE |
Assisted feed: 15g M Cut up Meloxicam: 0.20 ml (1.5 mg/ml soln) PO Ketorolac - OU -
|
2025-09-06 09:46 RE |
Assisted feed: 15g M Cut up Buprenorphine SR: 0.05 ml (1.8 mg/ml SR) SQ Meloxicam: 0.20 ml (1.5 mg/ml soln) PO Ketorolac - OU -
QAR, one pellet, normal mutes, no leftovers
|
2025-09-05 18:00 SAK |
Assisted feed: 18g M Cut up Meloxicam: 0.20 ml (1.5 mg/ml soln) PO Ketorolac - OU -
|
2025-09-05 09:49 SJ |
Assisted feed: 16g M Cut up Buprenorphine SR: 0.05 ml (1.8 mg/ml SR) SQ Meloxicam: 0.20 ml (1.5 mg/ml soln) PO Ketorolac - OU
QAR, one pellet, normal mutes, 10g leftovers
|
2025-09-04 16:51 MR |
31g M Buprenorphine SR: 0.05 ml (1.8 mg/ml SR) SQ Meloxicam: 0.20 ml (1.5 mg/ml soln) PO Ketorolac - OU - PT: PROM Left wing - under anesthesia
|
2025-09-04 14:23 AMS |
TPA Injection OD:
Proparacaine applied OD. Anesthetized with Iso/O2 via mask. OD prepped with dilute betadine. TPA 0.1ml injected into the anterior chamber by Dr. MS (ophtho). Evaluation several minutes later she felt subjectively already looked a bit clearer. Applied drop of ofloxacin OD.
Physical Therapy:
Removed L wing-to-body wrap. There is boney callus formation at the ulnar fracture site. Did PROM of carpus, elbow, and shoulder. Able to get adequate extension at the carpus and elbow. Replaced body wrap.
Recovered from anesthesia uneventfully.
AMS
|
2025-09-04 10:59 RE |
NPO Buprenorphine SR: 0.05 ml (1.8 mg/ml SR) SQ Meloxicam: 0.20 ml (1.5 mg/ml soln) PO Ketorolac - OU -
BAR, one pellet, normal mutes, no leftovers
|
2025-09-03 16:57 KT |
Assisted feed: 15g M Cut up Meloxicam: 0.20 ml (1.5 mg/ml soln) PO Ketorolac - OU -
|
2025-09-03 10:48 RE |
Assisted feed: 16g M Cut up Buprenorphine SR: 0.05 ml (1.8 mg/ml SR) SQ Meloxicam: 0.20 ml (1.5 mg/ml soln) PO Ketorolac - OU -
BAR, one pellet, normal mutes, 16g leftovers (was not assist fed in pm)
|
2025-09-02 17:38 RE |
Continue ketorolac OU BID, TPA injection scheduled for 9/4/25
recheck 1-2 weeks after 9/4
Eye exam |
Exam date - | 2025-09-02 | Examiner - | RE |
| RIGHT | LEFT | PLR | Menace | PLR | Menace | + | DNE | + | DNE | Stain | | Stain | | NEG | | NEG |   | Right eye: 1+ blepharospasm;
1+ mucoid;
AntCh: fibrin clot and hyphema;
| Left eye: 1+ mucoid;
AntCh: fibrin clot and hyphema;
|
|
|
2025-09-02 16:27 KT |
Food: 16g M Cut up Meloxicam: 0.20 ml (1.5 mg/ml soln) PO Ketorolac - OU -
|
2025-09-02 12:20 KT |
Weight: 313 grams Assisted feed: 15g M Cut up Buprenorphine SR: 0.05 ml (1.8 mg/ml SR) SQ Meloxicam: 0.20 ml (1.5 mg/ml soln) PO Ketorolac - OU -
BAR, No Pellet, No Leftovers, Normal Mutes
Wt: +8g 3% gain bw
|
2025-09-01 15:57 SAK |
Assisted feed: 15g M Cut up Meloxicam: 0.20 ml (1.5 mg/ml soln) PO Ketorolac - OU -
|
2025-09-01 12:44 AMS |
Scheduled for ophtho consult tomorrow AMS
Eye exam |
Exam date - | 2025-09-01 | Examiner - | AMS |
| RIGHT | LEFT | PLR | Menace | PLR | Menace | NEG | DNE | + | DNE | Stain | | Stain | | DNE | | DNE |   | Right eye: absent PLR, suspect blind in this
eye, concerned for posterior lens
luxation with large amount of vitreal
presentation, hyphema still visible
in anterior chamber | Left eye: hyphema still visible in anterior
chamber with either fibrin or vitreous
attached to both the blood clot
and the lens, appears visual in
this eye |
|
|
2025-09-01 11:58 SAK |
======= TREATMENT PLAN ======= Assisted feed: 15g M Cut up BID Buprenorphine SR: 0.05 ml (1.8 mg/ml SR) SID SQ Meloxicam: 0.20 ml (1.5 mg/ml soln) BID PO Ketorolac - OU BID - ============================== Update PT/NPO
|
2025-09-01 08:53 SAK |
Assisted feed: 16g M Cut up Buprenorphine SR: 0.05 ml (1.8 mg/ml SR) SQ Meloxicam: 0.20 ml (1.5 mg/ml soln) PO Ketorolac - OU -
No Regurg, 1 pellet, Urate/Feces present
|
2025-08-31 16:57 SAK |
Assisted feed: 15g M Cut up Meloxicam: 0.20 ml (1.5 mg/ml soln) PO Ketorolac - OU -
|
2025-08-31 12:02 SAK |
Assisted feed: 15g M Cut up Buprenorphine SR: 0.05 ml (1.8 mg/ml SR) SQ Meloxicam: 0.20 ml (1.5 mg/ml soln) PO Ketorolac - OU -
No regurge, no pellet, urates/feces present
|
2025-08-31 10:03 SAK |
======= TREATMENT PLAN ======= Assisted feed: 15g M Cut up BID Buprenorphine SR: 0.05 ml (1.8 mg/ml SR) SID SQ Meloxicam: 0.20 ml (1.5 mg/ml soln) BID PO Ketorolac - OU BID - ==============================
|
2025-08-30 18:35 RE |
Blood drawn from right jugular vein for intake labwork.
PCV/TP |
Collection date | 2025-08-30 18:35:00 | PCV | 37 % | TS | 4.0 g\dl | Serum | |
|
Blood lead |
Collection date | 2025-08-30 | Level | 0.00 |
|
Serum chemistry |
Collection date | 2025-08-30 | AST | 199 U/L | Phos | 4.1 mg/dl | BA | 0 umol/L | TP | 3.9 g/dl | CK | 1501 U/L | Alb | 2.3 g/dl | UA | 2.5 mg/dl | Glob | 1.6 g/dl | Glu | 294 mg/dl | K+ | 3.2 mmol/l | Ca | 10.7 mg/dl | Na+ | 156 mmol/l | | | AMY | 0 U/L | Hem 0, Lip 0, Ict 0 |
|
CBC |
Collection date | 2025-08-30 | WBC count | 20554 | Corrected count | 20554 | Hets/Neut | 29% - 5960 | Bands | 0+ | Toxics | 0+ | Lymphs | 51% - 10482 | Eos | 11% - 2260 | Mono | 9% - 1849 | Baso | 0% - 0 | Thrombocytes | adequate | PI | 1 | Hemoproteus | NEG | Leukocytozoon | NEG | Plasmodium | NEG | Read by | Moichor | |
|
|
2025-08-30 17:48 RE |
Food: 15g ch, m cut up tweezer fed plus food from AM Meloxicam: 0.20 ml (1.5 mg/ml soln) PO Ketorolac - OU -
|
2025-08-30 08:40 RE |
Food: 15g ch, m cut up Buprenorphine SR: 0.05 ml (1.8 mg/ml SR) SQ Meloxicam: 0.20 ml (1.5 mg/ml soln) PO Ketorolac - OU -
BAR, one pellet, normal mutes, did not eat five pieces left from last night
|
2025-08-30 07:39 RE |
======= TREATMENT PLAN ======= Food: 15g ch, m cut up BID Buprenorphine SR: 0.05 ml (1.8 mg/ml SR) SID SQ Meloxicam: 0.20 ml (1.5 mg/ml soln) BID PO Ketorolac - OU BID - ============================== switched to oral meloxicam
|
2025-08-29 16:46 RE |
Food: 26g cut up, assist fed, left 5 pieces in cage Meloxicam: 0.06 ml (5 mg/ml (Injectable)) IM (Switch to oral when eating) Ketorolac - OU -
|
2025-08-29 15:38 AMS |
Imagery report |
Date | 2025-08-29 | Type | Radiograph | Performed by | AMS | Positioning | VD, RLat, L wing CdCr | Equipment | | Location | AUCVM | Anesthesia | ISO via mask | Comments | Anesthetized with Iso/O2 via mask. No complications, uneventful recovery. There is a comminuted non-displaced fracture of the proximal diaphysis of the L ulna with a large butterfly fragment. The fracture does not appear to extend to to the joint. No other orthopedic or soft tissue abnormalities are seen. Images reviewed with Dr. RS. Replaced L wing-to-body wrap with 1" silk tape. |
|
|
2025-08-29 10:56 RE |
NPO Buprenorphine SR: 0.05 ml (1.8 mg/ml SR) SQ Meloxicam: 0.06 ml (5 mg/ml (Injectable)) IM (Switch to oral when eating) Ketorolac - OU - QAR, one pellet, normal mutes, 11g leftovers
|
2025-08-28 17:09 RE |
======= TREATMENT PLAN ======= Food: 15g ch, m cut up BID Buprenorphine SR: 0.05 ml (1.8 mg/ml SR) SID SQ Meloxicam: 0.06 ml (5 mg/ml (Injectable)) BID IM (Switch to oral when eating) Ketorolac - OU BID - ==============================
|
2025-08-28 16:55 RE |
Food: 14g ch, m cut up tweezer feed, left 20g in cage Buprenorphine SR: 0.05 ml (1.8 mg/ml SR) SQ Meloxicam: 0.06 ml (5 mg/ml (Injectable)) IM (Switch to oral when eating) Ketorolac - OU -
|
2025-08-28 08:54 RE |
Meloxicam: 0.06 ml (5 mg/ml (Injectable)) IM (Switch to oral when eating) Ketorolac - OU -
QAR, left two mouse heads, normal mutes, no pellet
|
2025-08-27 17:16 RE |
Food: 19g ch, m cut up assist fed Fluids: 10ml LRS Meloxicam: 0.06 ml (5 mg/ml (Injectable)) IM (Switch to oral when eating) Ketorolac - OU -
|
2025-08-27 15:02 RE |
======= TREATMENT PLAN ======= Food: 15g ch, m cut up BID Buprenorphine SR: 0.05 ml (1.8 mg/ml SR) SID SQ Meloxicam: 0.06 ml (5 mg/ml (Injectable)) BID IM (Switch to oral when eating) Ketorolac - OU BID - ==============================
|
2025-08-27 09:54 RE |
Food: 16g ch, m cut up tweezer fed all but two mice heads Buprenorphine SR: 0.05 ml (1.8 mg/ml SR) SQ Meloxicam: 0.06 ml (5 mg/ml (Injectable)) IM (Switch to oral when eating) Fluids: 10ml LRS Ketorolac - OU BID -
Brief Exam: -there is hyphema OU, p appears visual -there is a proximal diaphyseal fracture of the L ulna - placed in wing-to-body wrap -the ulnar veins are very small with delayed refill, gave 10ml LRS SQ -there is nystagmus intermittently when p is held, but was not noted prior to getting p out of enclosure AMS
|
2025-08-26 18:20 RE |
Sample |
Collection date | 2025-08-26 | Type | choanal/cloacal swab | Notes:
| Results: AI PCR : Not detected |
|
|
2025-08-26 17:01 MR |
Food: 16g ch, m cut up Meloxicam: 0.06 ml (5 mg/ml (Injectable)) IM (Switch to oral when eating)
|
2025-08-26 10:10 SO |
======= TREATMENT PLAN ======= Food: 15g ch, m cut up BID Buprenorphine SR: 0.05 ml (1.8 mg/ml SR) SID SQ Meloxicam: 0.06 ml (5 mg/ml (Injectable)) BID IM (Switch to oral when eating) ==============================
|
2025-08-26 10:10 SO |
======= TREATMENT PLAN ======= Buprenorphine SR: 0.05 ml (1.8 mg/ml SR) SID SQ Meloxicam: 0.06 ml (5 mg/ml (Injectable)) BID IM (Switch to oral when eating) ==============================
|
2025-08-26 10:06 SO |
Weight: 305 grams, BCS: 3.0
------------- PHYSICAL EXAM FINDINGS ---------------- Attending Veterinarian: Dr. Seth Oster Observational examination Mentation: Dull Posture: Standing Vital stats Heart rate: 350 Respiratory rate: 100 Auscultation: WNL Mucous membranes: Moist Hydration: Euhydration Oral cavity: Small amount of hemorrhage in oral cavity Beak: WNL Cere/nares: WNL Eyes: Unable to examine Ears: WNL Crop: WNL Feather quality: WNL Integument: WNL Wings: No palpable fractures Legs/Feet: No palpable fractures Neurologic: Horizontal Nystagmus and head tilt Ceolom: WNL BCS: 3 Vent: WNL Droppings: WNL Uropygial gland: WNL
Suspected acute head trauma. Unable to perform an ophtho exam while by myself. Administered 0.05mls buprenorphine SR sq and 0.06mls meloxicam IM. AI swab taken. Rec continuing pain medications, ophtho exam when possible, assist feed if not eating on own.
|
2025-08-26 08:31 RE |
Additional data from online form ------------------------
Offered food or water: Sugar water Treatments given: No Carrier box to pickup: No Add to mailing list: Yes
|